Hepatic-tone Liquid
NDC Package 64578-0085-1
Package Information
Hepatic-tone (carduus marianus, ceanothus americanus, chelidonium majus, chionanthus virginica, citricum acidum, cysteinum, hepar suis, leptandra virginica, magnesia muriatica, natrum sulphuricum, nux vomica, phosphorus, quassia (amara), taraxacum officinale) liquids is classified as a
- acidifying activity - [moa] (mechanism of action)
- allergens - [cs]
- anti-coagulant - [epc] (established pharmacologic class)
- calcium chelating activity - [moa] (mechanism of action)
- calculi dissolution agent - [epc] (established pharmacologic class)
- cell-mediated immunity - [pe] (physiologic effect)
- decreased coagulation factor activity - [pe] (physiologic effect)
- increased histamine release - [pe] (physiologic effect)
- increased igg production - [pe] (physiologic effect)
- increased large intestinal motility - [pe] (physiologic effect)
- inhibition large intestine fluid/electrolyte absorption - [pe] (physiologic effect)
- inhibition small intestine fluid/electrolyte absorption - [pe] (physiologic effect)
- magnesium ion exchange activity - [moa] (mechanism of action)
- non-standardized plant allergenic extract - [epc] (established pharmacologic class)
- osmotic activity - [moa] (mechanism of action)
- osmotic laxative - [epc] (established pharmacologic class)
- plant proteins - [cs]
- seed storage proteins - [cs]
- stimulation large intestine fluid/electrolyte secretion - [pe] (physiologic effect)
Identification & Billing
Clinical Specifications
- ANHYDROUS CITRIC ACID 8 [hp_X]/mL
- CEANOTHUS AMERICANUS LEAF 12 [hp_X]/mL
- CHELIDONIUM MAJUS 4 [hp_X]/mL
- CHIONANTHUS VIRGINICUS BARK 8 [hp_X]/mL
- CYSTEINE 8 [hp_X]/mL
- MAGNESIUM CHLORIDE 8 [hp_X]/mL
- MILK THISTLE 4 [hp_X]/mL
- PHOSPHORUS 12 [hp_X]/mL
- PORK LIVER 9 [hp_X]/mL
- QUASSIA AMARA WOOD 4 [hp_X]/mL
- SODIUM SULFATE 12 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED 12 [hp_X]/mL
- TARAXACUM OFFICINALE 4 [hp_X]/mL
- VERONICASTRUM VIRGINICUM ROOT 12 [hp_X]/mL
- Acidifying Activity - [MoA] (Mechanism of Action)
- Allergens - [CS]
- Anti-coagulant - [EPC] (Established Pharmacologic Class)
- Calcium Chelating Activity - [MoA] (Mechanism of Action)
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 64578 - Energetix Corporation
- 64578-0085 - Hepatic-tone
- 64578-0085-1 - 59.1 mL in 1 BOTTLE, DROPPER
- 64578-0085 - Hepatic-tone
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 64578-0085-1 identifies a specific commercial package of 59.1 ml in 1 bottle, dropper of Hepatic-tone, a human over the counter drug labeled by Energetix Corporation. This liquid is formulated for oral use and contains anhydrous citric acid; ceanothus americanus leaf; chelidonium majus; chionanthus virginicus bark; cysteine; magnesium chloride; milk thistle; phosphorus; pork liver; quassia amara wood; sodium sulfate; strychnos nux-vomica seed; taraxacum officinale; veronicastrum virginicum root as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energetix Corporation on May 29, 2014. The current certification is valid through December 31, 2026.
How is this Energetix Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 64578008501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.